Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.41 USD | -2.90% | +2.05% | +209.38% |
05-31 | Jasper Therapeutics, Inc. to Present Data on Briquilimab in Mast Cell Driven Diseases at the EAACI Congress 2024 | CI |
05-20 | Transcript : Jasper Therapeutics, Inc. - Special Call |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
JASPER THERAPEUTICS, INC. | Other Pharmaceuticals | -2.90% | +2.05% | +209.38% | +50.68% | - | 379M |
Technical Rankings Surperformance
- Stock Market
- Equities
- JSPR Stock
- Charts Jasper Therapeutics, Inc.
- Comparison Chart